The adjacent cardiac Cacna1g and Epn3 enhancers, located in an intron of Cacna1g, were targeted with sgRNAs (targeting GGGCACATCCCTCAGCAGCC and GGCCCAATTAGAAGCCACCC) using CRISPR/Cas9 technology, resulting in a 3345 bp deletion. (J:295904)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count